Corrections:
Correction: Monitoring EGFR-T790M mutation in serum/plasma for prediction of response to third-generation EGFR inhibitors in patients with lung cancer
Metrics: PDF 1634 views | ?
1 Medical Oncology Department, Catalan Institute of Oncology - Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
2 Medical Oncology Department, Catalan Institute of Oncology-Girona, Hospital Universitari Doctor Trueta Girona, Girona, Spain
3 Molecular Biology Laboratory of Cancer Dr. Rosell, Can Ruti Campus: Institute Germans Trias i Pujol (IGTP), Catalan Institute of Oncology, Badalona, Spain
4 Medical Oncology Department, Catalan Institute of Oncology - Hospital Duran i Reynalds, l’Hospitalet de Llobregat, Barcelona, Spain
5 Medical Oncology Department, Hospital Parc Taulí, Sabadell, Barcelona, Spain
6 Medical Oncology Department, Consorci Sanitari de Terrassa, Terrassa, Barcelona, Spain
7 Research Nurse Team, Catalan Institute of Oncology - Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
8 Statistics Department, Fundació Germans Trias i Pujol, Badalona, Spain
9 Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
Published: April 02, 2019
This article has been corrected: The correct affiliation information is given below:
1 Medical Oncology Department, Catalan Institute of Oncology - Badalona, Hospital Universitari Germans Trias i Pujol, Badalona, Department of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
Original article: Oncotarget. 2018; 9:27074-27086. https://doi.org/10.18632/oncotarget.25478
![Creative Commons License](/images/80x15.png)
PII: 26855